{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:21:49Z","timestamp":1785860509161,"version":"3.56.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,15]]},"DOI":"10.1097\/01.tp.0000209825.91632.ea","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T04:38:56Z","timestamp":1147235936000},"page":"1285-1289","source":"Crossref","is-referenced-by-count":44,"title":["Thymoglobulin Induction Is Safe and Effective in Live-Donor Renal Transplantation: A Single Center Experience"],"prefix":"10.1097","volume":"81","author":[{"given":"Karen L.","family":"Hardinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Labile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decha","family":"Enkvetchakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/01.TP.0000083895.64198.10","article-title":"Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.","volume":"76","author":"Campbell","year":"2003","journal-title":"Transplantation"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/01.TP.0000112435.51747.63","article-title":"Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial.","volume":"77","author":"Wiland","year":"2004","journal-title":"Transplantation"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1097\/00007890-200005150-00033","article-title":"Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors?","volume":"69","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0090-4295(03)00760-X","article-title":"Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols.","volume":"62","author":"Chkhotua","year":"2003","journal-title":"Urology"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded, comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00007890-200202150-00025","article-title":"Short course induction immunosuppression with Thymoglobulin for renal transplant recipients.","volume":"73","author":"Agha","year":"2002","journal-title":"Transplantation"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00007890-199712270-00036","article-title":"Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.","volume":"64","author":"Brennan","year":"1997","journal-title":"Transplantation"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.V81118","article-title":"Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.","volume":"8","author":"Brennan","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R10-11-20210129","article-title":"2003 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1992-2003.","year":"2004"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1432-2277.2000.tb01056.x","article-title":"Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis.","volume":"13","author":"Ekberg","year":"2000","journal-title":"Transpl Int"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007890-200109150-00017","article-title":"Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.","volume":"72","author":"Bumgardner","year":"2001","journal-title":"Transplantation"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti- interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.TP.0000132329.67611.3F","article-title":"Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.","volume":"78","author":"Hardinger","year":"2004","journal-title":"Transplantation"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/01.TP.0000135464.11616.5A","article-title":"Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival.","volume":"78","author":"Fuller","year":"2004","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124509-200609000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:26:21Z","timestamp":1785857181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200605150-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,15]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000209825.91632.ea","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5,15]]}}}